Real-world effectiveness of rezvilutamide plus androgen deprivation therapy in patients with high-volume metastatic hormone-sensitive prostate cancer: a retrospective multicenter cohort study.
Wang B, Xia D, Pan Y, Hu J, Liu H, Zhang X, Chen D, Huang H, Chen G, Fan J, Zhang H, Wu H, Li Z, Zhao G, Wang Q, Li L, Ye M, Yang G, Liu Y, Lin J, Gu Y, Liu F, Chen Z, Luo J, Wang L, Ying Z, He T, Lin C, Zhang X, Niu S.
Wang B, et al. Among authors: xia d.
Transl Androl Urol. 2026 Jun 30;15(6):216. doi: 10.21037/tau-2026-0456. Epub 2026 Jun 25.
Transl Androl Urol. 2026.
PMID: 42436774
Free PMC article.